NURS 6521 Week 9 discussion: Week 9: Women’s and Men’s Health/Infections and Hematologic Systems, Part I

NURS 6521 Week 9 discussion: Week 9: Women’s and Men’s Health/Infections and Hematologic Systems, Part I

 

Welcome to week 9
Posted on: Sunday, July 26, 2020 6:00:00 AM EDT

Dear Class,

Welcome to week 9 and 10, combined.
Topic: Discussion: Women’s and Men’s Health, Infectious Disease, and Hematologic Disorders, Part 1 and 2
For this Discussion, you will be assigned a patient case study and will consider how to address the patient’s current drug therapy plans. You will then suggest recommendations on how to revise these drug therapy plans to ensure effective, safe, and quality patient care for positive patient health outcomes.

We will write
a custom nursing essay or paper
specifically for you
Get your first paper with
15% OFF

To Prepare

Review the Resources for this module and reflect on the different health needs and body systems presented.
Your Instructor will assign you a complex case study to focus on for this Discussion. Last name A through M, CASE 1. Last name M through Z, CASE 2.
Consider how you will practice critical decision making for prescribing appropriate drugs and treatment to address the complex patient health needs in the patient case study you selected.
By Day 3 of Week 9

Post a brief description of your patient’s health needs from the patient case study you assigned. Be specific. Then, explain the type of treatment regimen you would recommend for treating your patient, including the choice or pharmacotherapeutics you would recommend and explain why. Be sure to justify your response. Explain a patient education strategy you might recommend for assisting your patient with the management of their health needs. Be specific and provide examples.

You will respond to your colleagues’ posts in Week 10

Case Study 1

HH is a 68 yo M who has been admitted to the medical ward with community-acquired pneumonia for the past 3 days. His PMH is significant for COPD, HTN, hyperlipidemia, and diabetes. He remains on empiric antibiotics, which include ceftriaxone 1 g IV qday (day 3) and azithromycin 500 mg IV qday (day 3). Since admission, his clinical status has improved, with decreased oxygen requirements. He is not tolerating a diet at this time with complaints of nausea and vomiting.

Ht: 5’8” Wt: 89 kg

Allergies: Penicillin (rash)

 

ORDER A PLAGIARISM-FREE PAPER HERE !!

 

Solution